Compugroup Medical Valuation
| COP Stock | EUR 14.02 1.02 6.78% |
At this time, the firm appears to be fairly valued. Compugroup Medical shows a prevailing Real Value of €14.1 per share. The current price of the firm is €14.02. Our model approximates the value of Compugroup Medical from analyzing the firm fundamentals such as Current Valuation of 2.74 B, return on equity of 0.12, and Profit Margin of 0.06 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Compugroup Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Compugroup Medical is based on 3 months time horizon. Increasing Compugroup Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Compugroup stock is determined by what a typical buyer is willing to pay for full or partial control of Compugroup Medical SE. Since Compugroup Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Compugroup Stock. However, Compugroup Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 14.02 | Real 14.1 | Hype 14.02 |
The real value of Compugroup Stock, also known as its intrinsic value, is the underlying worth of Compugroup Medical Company, which is reflected in its stock price. It is based on Compugroup Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Compugroup Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Compugroup Medical SE helps investors to forecast how Compugroup stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Compugroup Medical more accurately as focusing exclusively on Compugroup Medical's fundamentals will not take into account other important factors: Compugroup Medical Total Value Analysis
Compugroup Medical SE is currently estimated to have takeover price of 2.74 B with market capitalization of 2.34 B, debt of 587.08 M, and cash on hands of 44.29 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Compugroup Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.74 B | 2.34 B | 587.08 M | 44.29 M |
Compugroup Medical Investor Information
About 50.0% of the company shares are held by company insiders. The book value of Compugroup Medical was currently reported as 12.87. The company last dividend was issued on the 20th of May 2022. Compugroup Medical had 25:1 split on the 23rd of October 2006. Based on the analysis of Compugroup Medical's profitability, liquidity, and operating efficiency, Compugroup Medical SE is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Compugroup Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Compugroup Medical has an asset utilization ratio of 57.25 percent. This implies that the Company is making €0.57 for each dollar of assets. An increasing asset utilization means that Compugroup Medical SE is more efficient with each dollar of assets it utilizes for everyday operations.Compugroup Medical Ownership Allocation
Compugroup Medical holds a total of 52.23 Million outstanding shares. Compugroup Medical SE retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Compugroup Medical Profitability Analysis
The company reported the revenue of 1.03 B. Net Income was 68.97 M with profit before overhead, payroll, taxes, and interest of 411.46 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Compugroup Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Compugroup Medical and how it compares across the competition.
About Compugroup Medical Valuation
The stock valuation mechanism determines Compugroup Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Compugroup Medical. We calculate exposure to Compugroup Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Compugroup Medical's related companies.CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. CompuGroup Medical Societas Europaea was founded in 1979 and is headquartered in Koblenz, Germany. COMPUGROUP MED operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5000 people.
8 Steps to conduct Compugroup Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Compugroup Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Compugroup Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Compugroup Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Compugroup Medical's revenue streams: Identify Compugroup Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Compugroup Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Compugroup Medical's growth potential: Evaluate Compugroup Medical's management, business model, and growth potential.
- Determine Compugroup Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Compugroup Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Compugroup Stock analysis
When running Compugroup Medical's price analysis, check to measure Compugroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugroup Medical is operating at the current time. Most of Compugroup Medical's value examination focuses on studying past and present price action to predict the probability of Compugroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugroup Medical's price. Additionally, you may evaluate how the addition of Compugroup Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |